Company Filing History:
Years Active: 2018-2021
Title: Wanqing Liu: Innovator in siRNA Compositions for Chronic Liver Disease
Introduction
Wanqing Liu is a notable inventor based in Zionsville, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of siRNA compositions aimed at treating chronic liver diseases. With a total of 3 patents, Liu's work is paving the way for innovative therapeutic approaches.
Latest Patents
Liu's latest patents focus on siRNA compositions that specifically downregulate the expression of a variant of the PNPLA3 gene. These inventions provide methods for treating chronic liver disease and alcoholic liver disease (ALD). The siRNA compositions are designed to target the PNPLA3 gene variant, offering a promising avenue for therapeutic intervention in liver-related health issues.
Career Highlights
Wanqing Liu is affiliated with the Purdue Research Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to addressing significant health challenges through scientific discovery and application.
Collaborations
Liu collaborates with Yoon Yeo, who is also involved in research related to his innovative projects. Their partnership exemplifies the collaborative spirit often found in research institutions.
Conclusion
Wanqing Liu's contributions to the field of biotechnology, particularly in the development of siRNA compositions for chronic liver disease, highlight his role as a leading inventor. His work not only showcases his innovative spirit but also holds the potential to significantly impact the treatment of liver diseases.